id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-Z-2200-0004,FDA,FDA-2020-Z-2200,"Termination of the Food and Drug Administration’s Unapproved Drugs Initiative; Request for Information
Regarding Drugs Potentially Generally Recognized as Safe and Effective; Withdrawal",Notice,Withdrawal,2021-05-27T04:00:00Z,2021,5,2021-05-27T04:00:00Z,,2021-05-27T12:13:50Z,2021-11257,0,0,0900006484b3c958